Psoriasis and Psoriatic Arthritis

Helping to address unmet needs of people with psoriasis and psoriatic arthritis.

Psoriasis is a common, chronic skin condition that affects nearly 125 million people worldwide, and results in increased skin cell growth that may appear on the skin as raised, sometimes red, patches covered with a silvery buildup of dead skin cells. Additionally, approximately 38 million live with psoriatic arthritis — a potentially debilitating disease that involves significant pain to swelling in joints — and whose symptoms can impact a person’s everyday life, including common day-to-day activities.

As an emerging leader in the treatment of immune-mediated inflammatory conditions, Celgene continues to deliver groundbreaking work to address areas of unmet need, including for patients around the world living with psoriasis and psoriatic arthritis.

Advocacy & Collaboration

Research

Celgene remains committed to continue addressing the unmet needs of patients living with psoriasis and psoriatic arthritis

Resources

Celgene is dedicated to offering support to patients with psoriasis and psoriatic arthritis. Check out these resources.